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Abstract 
Spinal cord injury (SCI) results in paralysis below the injury and strategies are being 
developed that support axonal regrowth, yet recovery lags, in part, because many axons 
are not re-myelinated. Herein, we investigated strategies to increase myelination of 
regenerating axons by over-expression of platelet-derived growth factor-AA (PDGF) and 
noggin either alone or in combination in a mouse SCI model. Noggin and platelet-derived 
growth factor aa (PDGF) have been identified as factors that enhance recruitment and 
differentiation of endogenous progenitors to promote myelination. Lentivirus encoding 
for these factors were delivered from a multi-channel bridge, which we have previously 
shown creates a permissive environment and supports robust axonal growth through 
channels. The combination of noggin + PDGF enhanced total myelination of regenerating 
axons relative to either factor alone, and importantly, enhanced functional recovery 
relative to the control condition. The increase in myelination was consistent with an 
increase in oligodendrocyte-derived myelin, which was also associated with a greater 
density of cells of an oligodendroglial lineage relative to each factor individually and 
control conditions. These results suggest enhanced myelination of regenerating axons by 
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noggin + PDGF that act on oligodendrocyte-lineage cells post-SCI, which ultimately led 
to improved functional outcomes.  
Graphical Abstract 
Spinal cord injury (SCI) results in paralysis below the injury and strategies are being 
developed that support axonal regrowth, yet recovery lags, in part, because many axons 
are not re-myelinated. Herein, we investigated strategies to increase myelination of 
regenerating axons by over-expression of platelet-derived growth factor-AA (PDGF) and 
noggin either alone or in combination in a mouse SCI model. 
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Introduction 
Spinal cord injury (SCI) causes paralysis below the level of injury, which, at the 
cellular level, results from neuron and oligodendrocyte cell death, axonal loss, and 
demyelination(L. De Laporte et al., 2009; P. M. Richardson, U. M. Mcguinness, & A. J. 
Aguayo, 1980; H. M. Tuinstra et al., 2012). Though spinal cord neurons have an innate 
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capacity to regenerate, they are limited by a microenvironment that features an 
insufficient supply of factors that promote regeneration and an abundance of inhibitory 
factors including the glial scar(M. S. Beattie, G. E. Hermann, R. C. Rogers, & J. C. 
Bresnahan, 2002; M. B. Bunge, 2001; D. J. Donnelly & P. G. Popovich, 2008; M. T. 
Fitch & J. Silver, 2008; K. Kadoya et al., 2009; C. E. Schmidt & J. B. Leach, 2003; M. E. 
Schwab, 2002). Post-mitotic oligodendrocytes, the myelinating cells native to the central 
nervous system (CNS), infrequently myelinate regenerating axons as oligodendrocytes 
undergo apoptosis due to excitotoxicity and the inflammatory milieu(S. Casha, W. R. Yu, 
& M. G. Fehlings, 2001; G. L. Li, M. Farooque, A. Holtz, & Y. Olsson, 1999; J. M. Lytle 
& J. R. Wrathall, 2007). Remyelination by Schwann cell of the peripheral nervous system 
is observed, though it is expected that Schwann cell-derived myelin is less effective for 
CNS function(S.-X. Zhang, F. Huang, M. Gates, & E. G. Holmberg, 2013). Surviving 
oligodendrocytes are inefficient at proliferation or extensive migration that is necessary 
for the cells to myelinate the majority of regenerating axons(A. Almad, F. R. Sahinkaya, 
& D. M. Mctigue, 2011; J. M. Lytle & J. R. Wrathall, 2007). Thus, strategies are needed 
to overcome the inhibitory microenvironment to enhance the number of available 
oligodendrocytes, such as through the recruitment of endogenous progenitors, and 
supporting their capacity for myelination(A. Almad et al., 2011; F. Barnabe-Heider et al., 
2010; S. Mi et al., 2009; D. L. Sellers, D. O. Maris, & P. J. Horner, 2009).  
Modulating the microenvironment following injury has proven to be difficult, with a 
multitude of cell, gene, and biomaterial approaches having been evaluated. 
Transplantation of Schwann cells, stem cells, or cells genetically engineered to secrete 
inductive factors have been used to shift the microenvironment towards a pro-
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regenerative phenotype(B. K. Chen et al., 2017; J. Fortun, C. E. Hill, & M. B. Bunge, 
2009; D. D. Pearse & D. J. Barakat, 2006). However, the impact of cell transplantation is 
frequently limited by the extent of survival and engraftment(J. Li & G. Lepski, 2013; W. 
Tetzlaff et al., 2011), which may not provide factors for times that are necessary to 
promote regeneration. Alternatively, injection of proteins into the lesion space or the 
spinal cord parenchyma has been employed to deliver trophic factors, yet these strategies 
cannot sustain the presence of these factors due to their clearance or degradation. Gene 
delivery represents a versatile strategy in which transduced cells function as bioreactors 
for the localized production of trophic factors to create a permissive environment for 
regeneration. We have previously reported that poly (lactide-co-glycolide) (PLG) multi-
channel bridges are an effective vehicle for localized, sustained lentiviral gene therapy 
capable of altering the post-injury microenvironment and promoting regeneration(H. M. 
Tuinstra et al., 2012). PLG has been widely used as a material for spinal cord repair or 
peripheral nerve conduits. PLG is also biodegradable, bioresorbable, and its degradation 
products are cleared by the body (M. Wang et al., 2011). Lentiviral expression is highest 
at the site of the implant and decreases as a function of distance. The lentivirus transduces 
cells in the surrounding area including astrocytes, macrophages, fibroblasts, and invading 
Schwann cells (H. M. Tuinstra et al., 2012). Additionally, these bridges feature an 
architecture that encourages axon growth through channels and infiltration of supporting 
cells into interconnected pores(H. M. Tuinstra et al., 2012; H. M. Tuinstra et al., 2014). 
Regenerating axons have been observed growing through the bridge and into tissue 
caudal to the injury(K. Pawar et al., 2015). However, the bridge alone is limited in its 
ability to foster remyelination. We have previously reported on the combinatorial 
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delivery of sonic hedgehog (SHH) and neurotrophin 3 (NT3) to improve myelination of 
regenerating axons. SHH and NT3 are reported to promote neurite extension that is 
dependent on the concentration and spatial/temporal distribution(A. C. Delgado et al., 
2014; E. Marti & P. Bovolenta, 2002), with SHH also influencing neuronal and 
oligodendrocyte differentiation during development and following injury(A. Gritli-Linde, 
P. Lewis, A. P. Mcmahon, & A. Linde, 2001; N. Lowry et al., 2012). While SHH alone, 
but not its combination with NT3, was able to enhance the percentage of axons 
myelinated by oligodendrocytes, the overall percentage of myelinated axons was lower 
than normally found in the contralateral tissue. This could be attributed to NT3 promoting 
Schwann cell recruitment and progenitor quiescence(A. C. Delgado et al., 2014). SHH 
has also been associated with ventral patterning, but has not been shown to enhance 
progenitor recruitment necessary to generate myelinating oligodendrocytes(V. Ribes & J. 
Briscoe, 2009). Factors that more effectively recruit the endogenous progenitor pool 
toward an oligodendrocyte lineage may further enhance myelination. 
Noggin and platelet-derived growth factor aa (PDGF) have been identified as factors 
that enhance recruitment and differentiation of endogenous progenitors to promote 
myelination in vitro and in vivo. Noggin is a bone morphogenetic protein (BMP) receptor 
antagonist(A. Liu & L. A. Niswander, 2005). BMPs, which are upregulated after SCI, 
promote astrocyte differentiation of proliferating progenitor cells. Although noggin 
inhibits the BMP pathway, it is not sufficient to increase the overall differentiation of 
progenitor cells to myelinating oligodendrocytes(G. U. Enzmann et al., 2005). PDGF 
specifically, has been noted for its capacity to enhance proliferation and recruitment of 
progenitor cells both in vitro and in vivo(Y. Chen et al., 2007; R. A. Hill, K. D. Patel, J. 
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Medved, A. M. Reiss, & A. Nishiyama, 2013; R. H. Woodruff, M. Fruttiger, W. D. 
Richardson, & R. J. Franklin, 2004; H. Zhang, L. Vutskits, V. Calaora, P. Durbec, & J. Z. 
Kiss, 2004). PDGF is a potent mitogen for progenitor cell proliferation(K. Asakura, S. F. 
Hunter, & M. Rodriguez, 1997; R. H. Woodruff et al., 2004) and is a required signaling 
molecule for differentiation of embryonic and adult neural stem cells into O4+ 
oligodendrocytes(M. Bradl & H. Lassmann, 2010; G. L. Hinks & R. J. Franklin, 1999; J. 
G. Hu et al., 2008). These reports elucidated how inductive factors can increase 
progenitor activity after SCI and even encourage spontaneous remyelination of spared 
axons(J. Lasiene, L. Shupe, S. Perlmutter, & P. Horner, 2008; B. E. Powers et al., 2012; 
B. E. Powers et al., 2013); however, the ability of these endogenous progenitors to 
potentiate myelination of large numbers of newly regenerating axons has not been 
determined.  
In this report, we investigated noggin and PDGF individually or in combination for 
their ability to enhance myelination of regenerating axons growing through a biomaterial 
bridge implanted into an acute spinal cord lesion. A mouse lateral hemisection model was 
used, with immediate intervention with PLG bridges inserted into the injury to deliver 
lentiviral vectors for sustained and localized expression noggin and/or PDGF (D. J. 
Margul et al., 2016; A. M. Thomas et al., 2014). Immunohistochemistry (IHC) was 
initially employed to quantify the extent of axon growth and myelination, and functional 
recovery was quantified using the Basso Mouse Scale (BMS) scale. As myelination can 
occur from CNS-derived oligodendrocytes or PNS-derived Schwann cells, we quantified 
the source of myelinating cells, as well as the density of cells within the oligodendrocyte 
lineage. Collectively, these studies demonstrate the potential for synergy between 
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biomaterials to guide tissue growth and the localized expression of factors to modulate 
the local environment and enhance the recruitment of endogenous progenitors that can 
restore function.  
Materials and Methods 
Virus production and validation  
HEK-293FT cells (80-90% confluent, American Type Culture Collection (ATCC), 
Manassas, VA, USA) were transfected with third generation lentiviral packaging vectors 
and pLenti-CMV-Luciferase, pLenti-CMV-noggin, or pLenti-CMV-PDGF. Correct 
insertion was validated via DNA sequencing. Plasmids were incubated in OptiMEM (Life 
Technologies, Carlsbad, CA, USA) with Lipofectamine 2000 (Life Technologies) for 20 
minutes prior to being added to cells. After 48 hours of incubation, supernatant was 
collected, centrifuged to remove cellular debris, and then incubated with PEG-It (System 
Biosciences, Palo Alto, CA, USA) for 16-24 hours at 4°C. Virus was centrifuged at 
1500g at 4°C for 30 min, supernatant was removed, and the pellet was re-suspended in 
sterile phosphate buffered saline (PBS; Life Technologies). Viral solution was aliquoted 
and frozen at -80°C until use. Viral titers used throughout the study were 3E9 IU/mL as 
determined by the Lentivirus qPCR Titer Kit (Applied Biological Materials, Richmond, 
BC, Canada).  
Fabrication of multi-channel bridges 
Bridges were fabricated using a sacrificial template variation(J. Li, T. A. Rickett, & 
R. Shi, 2009) of the gas foaming/particulate leaching technique, as previously 
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described(A. Thomas et al., 2013; H. M. Tuinstra et al., 2012). Briefly, PLG (75:25 
lactide:glycolide; i.v. 0.76 dL/g; Lakeshore Biomaterials, Birmingham, AL, USA) was 
dissolved in dichloromethane (6% w/w) and emulsified in 1% poly (ethylene-alt-maleic 
anhydride) using a homogenizer (PolyTron 3100; Kinematica AG, Littau, Switzerland) to 
create microspheres (z-average diameter ~1µm). D-sucrose (Sigma Aldrich), D-glucose 
(Sigma Aldrich), and dextran MW 100,000 (Sigma Aldrich) were mixed at a ratio of 
5.3:2.5:1 respectively by mass. The mixture was caramelized, cooled, and drawn from 
solution with a Pasteur pipette to make sugar fibers. Fibers were drawn to 150 – 250 µm, 
coated with a 1:1 mixture of PLG microspheres and salt (63-106 µm) and pressed into a 
salt-lined aluminum mold. The sugar strands were used to create 7 channels and the salt 
create a porous structure. The materials were then equilibrated with CO2 gas (800 psi) for 
16 h and then gas foamed in a custom-made pressure vessel. Bridges were subsequently 
cut into 2.25 mm sections and leached for 2 h to remove porogen. The bridges are dried 
overnight and stored in a desiccator.  
Virus loading into bridges 
Viruses were adsorbed onto bridges, with multiple steps to increase lentiviral loading. 
Prior to virus addition, bridges were disinfected in 70% ethanol and washed with sterile 
water. Bridges were then dried by touching sterile filter paper to the bridge. Bridges were 
then saturated with 2 µL of virus. After 2 minutes of incubation, sterile filter paper was 
touched to the surface of the bridge to remove excess moisture. This process was then 
repeated until a total of 8 μL of virus was added. After the final addition, the bridges were 
not dried with filter paper and were stored on ice until use. Bridges were used within 3 
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hours of coating with lentivirus. Lentivirus loading conditions included FLuc, PDGF, 
noggin, and noggin + PDGF. Lentiviral loading was done to ensure the same number of 
lentiviral particles per bridge. 
Mouse spinal cord hemisection 
All animal procedures were approved and in accordance with the Institutional Animal 
Care and Use Committee at the University of Michigan. A hemisection model of SCI was 
performed as previously described(A. Thomas et al., 2013) on female C57BL/6 mice (6-8 
weeks old; Jackson Laboratories). After administration of bupivacaine (.8 ml/kg), a 
laminectomy was performed at T9-T10 to allow for a 2.25 mm lateral hemisection for 
immediate bridge implantation. The injury site was covered using Gelfoam (Pfizer, New 
York, NY, USA) followed by suturing together of the muscle and stapling of skin. 
Postoperative care consisted of administration of enrofloxacin (2.5 mg/kg; daily for 2 
weeks), buprenorphine (0.1 mg/kg; twice daily for 3 days), and Lactated Ringer’s 
solution (5 mL/100 g; daily for 5 days). Bladders were expressed twice daily until 
function recovered. 
Immunohistochemistry and quantitative analysis of nerve regeneration, myelination, and 
NPC differentiation  
Spinal cords were extracted 8 weeks after SCI and flash frozen in isopentane. For 
immunofluorescence, spinal cord segments were embedded in Tissue Tek O.C.T. 
Compound (Sakura Finetek, Torrance, CA, USA) with 30% sucrose. Cords were cryo-
sectioned transversely in 18-μm-thick sections. Antibodies against the following antigens 
were used for immunofluorescence: neurofilament 200 (NF-200, Sigma Aldrich), myelin 
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basic protein (MBP, Santa Cruz Biotech, Dallas, TX, USA), Protein-zero myelin protein 
(P0, Aves Labs, Tigard, OR, USA), Sox2 (Abcam), Olig2 (Millipore), NG2 (Millipore), 
and O4 (Millipore). Tissues were imaged on an Axio Observer Z1 (Zeiss, Oberkochen, 
Germany) using a 10x/0.45 M27 apochromatic objective and an ORCA-Flash 4.0 V2 
Digital CMOS camera (C11440-22CU, Hamamatsu Photonics, Hamamatsu City, 
Shizuoka, Japan) or Nikon A1+ (Nikon Inc., Garden City, NY) using a 60x/1.4 
apochromatic objective. 
To assess the numbers of regenerated and myelinated axons within the PLG bridge 
area, NF-200 was used to identify axons, NF-200+/MBP+ to determine the number of 
myelinated axons, and NF-200+/MBP+/P0+ to determine the amount of myelin derived 
from infiltrating Schwann cells(A. M. Thomas et al., 2014). Twenty-one tissues 
distributed between conditions were counted by 2 blinded counters to calibrate software 
for automated counting developed by McCreedy et al(D. A. Mccreedy et al., 2016). In 
short, images were imported into MATLAB and the area of the section corresponding to 
PLG bridge was outlined. A Hessian matrix was created by convolution filtering using 
second derivative of the Gaussian function in the x, y, and xy directions. Eigenvalues 
were determined by extracted from the Hessian matrix and used to reconstruct the 
original image. Following filtering, positive NF-200 events were identified by intensity 
threshold, single pixel events were removed, and the number of connected objects were 
identified. This ensures highly branching axons are counted as one object and long axons 
are also counted as one object. For calibration, the software will output a matrix of 
potential axon counts based on this method. These values are directly compared to 
manual counts for the initial 22 tissues used for calibrating the software. The appropriate 
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filter size and threshold sensitivity are selected based on the correlation between the 
manual and automated counts to properly calibrate the software for use in quantifying the 
remaining tissues that had not been manually counted. To obtain axon densities, total NF-
200 counts were divided by the area of the PLG bridge. MBP and P0 events were 
identified similarly. NF-200 objects containing pixel locations overlapping with positive 
MBP or P0 staining were counted and compared to total NF-200 counts. To ensure 
proper calibration, Pearson’s coefficients were compared between counters and between 
the software and the counter averages.  
Nine tissues were selected randomly from the rostral, middle, and caudal section of 
the bridge implant from each animal (n=6) of each condition to be counted for 
progenitors and differentiated cells. Immunopositive cells within the PLG bridges were 
counted manually by four researchers independently. Due to PLG material generally 
exhibiting high background, cells were counted as Olig2 or Sox2 positive only when 
appearance of these markers spatially overlapped Hoechst 33342 counterstaining. Co-
staining for multiple markers was always assessed by evaluating overlap of pixels above 
a set threshold in images acquired over identical sample areas. Co-localization of Sox2 
and Olig2, was evaluated to determine the numbers of NPCs and OPCs. To quantify 
densities, total immunopositive cells were divided by the area of PLG outlined. 
Behavioral analysis 
The Basso mouse scale (BMS) open-field locomotor test was used to evaluate 
functional recovery over period of 8 weeks after SCI as previously described(D. M. 
Basso et al., 2006) for FLuc (n=12) and noggin + PDGF (n=12) conditions. A baseline 
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was determined prior to SCI, and the mice were tested at 1, 2, 4, 6, and 8 weeks. 
Observations and BMS scoring were performed by two blinded observers for 4 minutes 
per animal.  
Statistical analysis 
For multiple comparisons, statistical significance between groups was determined by 
one-way or two-way ANOVA with Bonferroni’s post-hoc. For single comparisons, the 
statistical significance between pairs was determined by unpaired t-test. All statistics test 
significance using a α value of 0.05. Error bars represent standard error in all figures. 
Prism 7 (GraphPad Software, La Jolla, CA, USA) software was used for all data analysis. 
Data Availability 
The datasets generated during and/or analyzed during the current study are available 
from the corresponding author on reasonable request. 
Results 
Lentiviral construct validation 
Initial studies validated the lentiviral constructs encoding noggin and PDGF. HEK-
293FT cells were transduced with a multiplicity of infection (MOI) of 10 viral particles 
per cell with noggin-encoding lentivirus. After 3 days, expression of noggin was assessed 
with anti-noggin antibody with Hoechst 33342 counterstaining (Fig. 1A-C). There was 
substantial staining with anti-noggin antibodies throughout cells transduced with 
lentivirus. There is also substantial staining of noggin in the cytosol. PDGF 
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overexpression was validated by transducing HEK-293FT cells with MOI 10 of PDGF 
lentivirus and quantifying protein level with an ELISA kit. PDGF protein expression 
increased 4-fold over cell transduced with FLuc lentivirus.  
Increased axon numbers and myelination post injury 
We quantified axonal density as a function of FLuc, noggin, PDGF, or co-delivery of 
both factors from the bridge. Axons (NF-200+) were present throughout the bridges (Fig. 
2A-D) 8 weeks after SCI in all experimental conditions. NF-200+ axons were typically 
observed in small groups or bundles as previously reported for multi-channel PLG 
bridges(D. A. Mccreedy et al., 2016; H. M. Tuinstra et al., 2012). FLuc bridges had a 
mean of approximately 800 axons/mm2, single lentiviral conditions had approximately 
1100 axons/mm2, and noggin + PDGF had approximately 1200 axons/mm2 (Fig. 2E). 
However, these differences were not statistically significant.  
Myelinated axons (NF-200+/MBP+; Fig. 3A-D) were present throughout bridge 
implants and typically appeared in bundles of multiple axons as previously reported. 
Myelinated axon density in the bridge implants was significantly enhanced, 
approximately 3-fold by co-delivery of noggin + PDGF relative to FLuc controls (Fig. 
3E). While single lentiviral vector delivery increased the density of myelinated axons 
compared to the FLuc control, it was not significant. The percentage of axons myelinated, 
which was determined from the ratio of NF-200+/MBP+ axons divided by total number of 
NF-200+ axons, was approximately 30% with no differences between groups for the 
control and individual factor expression (Fig. 3F); however, combined noggin + PDGF 
delivery resulted in a significantly higher percentage of myelinated axons at 44%.  
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Enhanced motor function recovery with combinatorial delivery 
We subsequently investigated the capacity for the combination of PDGF + noggin, 
which enhanced myelinated, to improve functional recovery. Bridges loaded with noggin 
+ PDGF were implanted into the lateral hemisection, with a control cohort receiving 
FLuc, and motor function was evaluated for 8 weeks post-SCI using the BMS (Fig. 4). 
Prior to surgery, all mice were fully functional with perfect scores (BMS = 9). At 1-week 
post-SCI, all mice had no movement in the ipsilateral hindlimb. From week 4 onward, 
mice receiving noggin + PDGF co-delivery had significantly improved function in 
comparison to mice that received bridges with FLuc lentivirus. Mice receiving noggin + 
PDGF lentivirus earned an average BMS score of approximately 4.2, with a score of 4 
indicating occasional stepping. By comparison, mice from the control condition mice 
scored at an average of approximately 1.5, which indicates ankle movement, yet an 
inability to achieve paw placement or perform stepping.  
Source of myelination post injury 
The source of myelination in the bridge was subsequently characterized to further 
investigate the correlation between increased myelination and motor function recovery. 
Histological sections were immunostained to identify Schwann cell (NF-200+/MBP+/P0+) 
or oligodendrocyte-derived myelin (NF-200+/MBP+/P0-) (Fig. 5A – D). No significant 
difference in density of Schwann cell myelinated axons between conditions was 
observed. In control, noggin, and PDGF conditions, the density of oligodendrocyte-
derived myelin was approximately 100 neurites/mm2. Overexpression of noggin + PDGF 
resulted in approximately 250 neurites/mm2, a significant 2.5-fold increase (Fig. 5E). The 
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percentage of oligodendrocyte-derived myelin was determined as the ratio of number of 
NF-200+/MBP+/P0- axons divided by the total number of NF-200+ axons. Overexpression 
of noggin or PDGF alone resulted in similar percentages of oligodendrocyte-derived 
myelin as control animals at 11-13%. Combined overexpression of noggin + PDGF 
significantly increased the level of total axons myelinated by oligodendrocytes to 22% 
relative to all experimental conditions (Fig. 5F).  
Recruitment and differentiation of endogenous progenitors 
The increase in CNS-derived oligodendrocyte myelination of regenerating axons at 8 
weeks post-injury within the bridge was subsequently interrogated by quantifying the 
density of cells within the oligodendroglial lineage. The presence of oligodendrocytes 
was evaluated by staining for O4 (Fig. 6A-D). Few O4+ pre-oligodendrocytes were 
observed in controls (Fig. 6J). A significant increase in O4+ cells for noggin + PDGF 
overexpression was observed compared to all other experimental conditions (Fig. 6J).  
Cells in the oligodendrocyte lineage (O4+) can arise from either neural progenitor 
cells (NPCs) that are Sox2+, or from glial-restricted progenitors (Olig2+/Sox2- or NG2+), 
which were subsequently analyzed. This analysis was performed at the 8-week time 
point, which would provide enough time for the progenitors to develop along the multiple 
lineages. For glial-restricted OPCs (Fig. 6B), no significant differences in the density of 
Olig2+/Sox2- cells or NG2+ cells across experimental conditions were observed (Fig. 6L). 
However, the density trended toward an increase in NG2+ stained cells for all conditions 
compared to control (Fig. 6K). Similar levels of NG2+ cells levels were present for 
noggin, PDGF, and combination of noggin + PDGF overexpression.  
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For NPCs (Sox2+), noggin over-expression resulted in no significant difference in 
number of Sox2+ cells relative to FLuc delivery (Fig. 6L). In contrast, PDGF over-
expression trended towards elevated numbers of Sox2+ cells relative to noggin over-
expression. Interestingly, the combination of noggin + PDGF had an additive effect, 
producing significantly more Sox2+ cells relative to noggin over-expression alone. We 
subsequently assessed the co-localization of Sox2 and Olig2 markers, which represents 
Sox2+ NPCs in the process of differentiating along oligodendrocyte lineages that leads to 
nuclear expression of Olig2(F. Barnabe-Heider et al., 2010; H. J. Lee, J. Wu, J. Chung, & 
J. R. Wrathall, 2013; H. Sabelstrom, M. Stenudd, & J. Frisen, 2014). A significant 
increase in density of Sox2+/Olig2+ cells was observed with PDGF overexpression 
compared to noggin and noggin + PDGF overexpression (Fig. 6L), indicating a greater 
number of NPCs differentiating into OPCs. Collectively, these studies suggest that the 
combination of PDGF + noggin enhances the recruitment of both glial-restricted 
progenitors and NPCs toward an oligodendrocyte lineage.  
Discussion 
We investigated remyelination of regenerating axons by endogenous cells responding 
to lentiviral induced trophic factor production by cells recruited into PLG multi-channel 
bridges implanted into a T9-10 mouse lateral hemisection SCI. We have previously 
reported axonal growth post-SCI through an aligned linear multichannel bridge which 
also provides a porous structure for cellular infiltration(H. M. Tuinstra et al., 2012; H. M. 
Tuinstra et al., 2014; Y. Yang et al., 2009). These bridges are a valuable tool to study the 
spinal cord microenvironment post-injury and investigate treatments in a controlled and 
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defined manner. The bridges are acellular, indicating that any cells, extracellular matrix, 
or proteins present in the bridge at the time of extraction must have originated from the 
host tissue. Similarly, any axons entering the implant must be attributed to either 
regeneration of injured axons or sprouting of new axons from spared or contralateral 
tissue. This bridge provides a defined space for histological analysis, analysis of cell 
populations at and near the lesion site, and treatment outcomes. The bridge alone has 
supported robust axon ingrowth, myelination, and recovery of some motor function(K. 
Pawar et al., 2015). These bridges also provide a vehicle for lentiviral delivery resulting 
in long-term, localized transgene expression with delivery of multiple factors which is 
difficult to achieve and generally requires the use of osmotic pumps(A. M. Thomas et al., 
2014; H. M. Tuinstra et al., 2012). Osmotic pumps can clog, require surgery for removal, 
and can cause further tissue damage. Other reports have used direct injection of vectors, 
which may not localize delivery to the injury. Unlike other viral vectors, lentivirus does 
not influence the phenotype of progenitors(S. M. Hughes, F. Moussavi-Harami, S. L. 
Sauter, & B. L. Davidson, 2002) or cause significant inflammation(A. A. Abdellatif et al., 
2006). The physical properties of lentiviral vectors are independent of the encoding gene, 
which allows for the exchange of vectors or the potential to deliver multiple vectors 
encoding various inductive factors without modification to the base biomaterial creating a 
high-throughput system. In these studies, we delivered two distinct transgenes from PLG 
bridges alone and in combination. We have previously demonstrated sustained expression 
for a minimum of 12 weeks, with peak expression localized within the bridge and 
decreased expression both rostral and caudal to the bridge(A. M. Thomas & L. D. Shea, 
This article is protected by copyright. All rights reserved. 
 
A
ut
ho
r 
M
an
us
cr
ip
t 
2013). This expression pattern ensures the delivered factors can have prolonged, targeted 
effects on cells within the intact tissue and infiltrating cells within the bridge. 
Co-delivery of noggin + PDGF significantly increased the density of myelinated 
axons and achieved the largest percentage of myelinated axons (44%) and 
oligodendrocyte-derived myelin (22%) that we have observed. While, co-delivery of 
noggin + PDGF did not significantly increase axon density versus control, the 
combination did enhance myelination relative to individual factors or control. For 
comparison to the extent of myelination, delivery of SHH and NT3 in our previous 
studies only resulted in ~30% of myelinated axons and ~13% of oligodendrocyte-derived 
myelin when compared to total axon counts(A. M. Thomas et al., 2014). Current 
estimates of myelinated axons in healthy spinal cord of rodent models range from 40 – 
60%(K. Chung & R. E. Coggeshall, 1983a, 1983b; J.-Y. C. Hsu, S. A. Stein, & X.-M. 
Xu, 2006). Therefore, this represents a significant result in the enhancement of axon 
myelination. Reports from other systems have demonstrated varying degrees of 
remyelination via delivery of single factors(A. Alizadeh et al., 2017; B. T. Tan et al., 
2017) or cell transplantation(Q. Cao et al., 2010; B. K. Chen et al., 2017; L. X. Deng et 
al., 2013; S. Karimi-Abdolrezaee, E. Eftekharpour, J. Wang, C. M. Morshead, & M. G. 
Fehlings, 2006), with these reports not achieving the myelination levels reported herein. 
Lack of myelination has been demonstrated to be a significant hindrance to recovery of 
function to regenerating axons(I. D. Duncan, A. Brower, Y. Kondo, J. F. Curlee, & R. D. 
Schultz, 2009; I. D. Duncan, R. L. Marik, A. T. Broman, & M. Heidari, 2017), and we 
employed the BMS and identified a significant increase in motor function improvement 
after SCI compared to control. This result suggests the difference in myelination density 
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and percentage may contribute in part to the improved functional outcomes. This result is 
consistent with other research suggesting remyelination contributes to normal function 
recovery(I. D. Duncan et al., 2009). Another interesting outcome is that no difference in 
Schwann cell myelin between groups was observed, yet only the noggin/PDGF 
combination resulted in improved functional outcome, potentially due to the differences 
in oligodendrocyte-derived myelination. Oligodendrocyte-derived myelin has been 
reported to be thicker and more supportive of axonal growth. This suggests that 
oligodendrocyte-derived myelin is necessary for return of function and Schwann cell 
myelin is inefficient.  
The increased myelination and functional recovery were associated with a greater 
recruitment of progenitor cells into the oligodendrocyte lineage. Post injury, 
oligodendrocyte-lineage cells have been reported to migrate from the spared tissue to 
repopulate lost cell populations(G. W. J. Hawryluk & M. G. Fehlings, 2008). These 
progenitor cells proliferate extensively between 24 hours to 2 weeks post injury but these 
populations are reduced at later timepoints (L. L. Horky, F. Galimi, F. H. Gage, & P. J. 
Horner, 2006; D. L. Sellers et al., 2009). Therefore, many progenitor cell populations 
would not be expected to be present in the bridges at 8 weeks post-injury without trophic 
factor expression. Our results with the control bridge (i.e., FLuc expression) are 
consistent with the relatively low density of progenitor cells populations. However, the 
delivery of lentivirus encoding for noggin, PDGF, or noggin/PDGF combination for 
sustained transgene expression altered the recruitment and differentiation of progenitor 
cells. At 8 weeks post-injury, endogenous progenitor pools were present within the bridge 
with trophic factor delivery. NPCs (Sox2+) can differentiate into OPCs (Olig2+, NG2+) by 
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exposure to various factors, and OPCs can differentiate into multiple other cell types 
including oligodendrocytes, astrocytes, Schwann cells, and neurons(V. E. Miron, T. 
Kuhlmann, & J. P. Antel, 2011). At the O4+ stage, the cells are lineage locked into 
becoming mature, myelinating oligodendrocytes. Noggin expression at the bridge would 
be expected to block the receptors for BMP 2/4/7, which would normally act to inhibit 
NPC differentiation and migration (A. Liu & L. A. Niswander, 2005; J. K. Sabo, T. D. 
Aumann, D. Merlo, T. J. Kilpatrick, & H. S. Cate, 2011; Q. Xiao, Y. Du, W. Wu, & H. 
K. Yip, 2010). The decreased presence of NPCs relative to control with noggin 
expression is consistent with inhibiting the action of BMPs, which would allow 
differentiation of NPCs toward an oligodendrocyte lineage. Although noggin alone 
increased the presence of O4+ oligodendrocytes, noggin alone was insufficient to induce 
myelination of large numbers of regenerating axons. 
Delivery of PDGF-encoding lentiviral vectors from the bridge significantly increased 
the presence of OPCs (Sox2+/Olig2+). PDGF in the spinal cord elicits multiple effects on 
OPCs, such as increasing the proliferation(Ying Chen et al., 2007; R. A. Hill et al., 2013; 
R. H. Woodruff et al., 2004) and differentiation(M. Bradl & H. Lassmann, 2010; J. G. Hu 
et al., 2008; C. Lutton et al., 2012) of OPCs at lesions. In contrast, in vitro culture studies 
with oligodendrocytes indicated an inhibition of myelinating properties(Z. Wang, H. 
Colognato, & C. Ffrench-Constant, 2007), and has been reported to delay 
oligodendrocyte differentiation and axonal myelination in vivo during development(A. 
M. Butt, M. F. Hornby, S. Kirvell, & M. Berry, 1997). However, the distinct effects of 
PDGF may depend on its temporal availability during proliferation, differentiation, and 
myelination(A. Barateiro & A. Fernandes, 2014), as withdrawal of this growth factor 
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triggers cell-cycle exit and differentiation(J. J. Boulanger & C. Messier, 2014). Herein, 
lentivirus was used for the sustained expression of PDGF for the 8-week study resulting 
in increased OPC density. However, these increases in OPC density did not contribute to 
increased density of O4+ pre-oligodendrocytes, which is consistent with the lack of 
increased myelination and oligodendrocyte-derived myelin relative to control. 
Conditional expression systems such as the tetracycline system have been used for 
temporal control of lentiviral expression (X. Zhou, M. Vink, B. Klaver, B. Berkhout, & 
A. T. Das, 2006). This type of viral delivery system could allow for PDGF to be 
expressed transiently to encourage further maturation of OPCs.  
Interestingly, combined delivery of noggin + PDGF encoding lentivirus significantly 
increased the presence of O4+ pre-oligodendrocytes. The noggin + PDGF overexpression 
significantly increased Sox2+/Olig2- cell density compared to noggin alone and had 
similar density compared to PDGF. This result suggests the decrease in Sox2+/Olig2- 
caused by noggin delivery may have been offset by PDGF co-delivery. Co-delivery also 
resulted in significantly lower densities of Olig2+ cells compared to other conditions. 
However, the density of O4+ pre-oligodendrocytes was increased 4-fold relative to 
control and PDGF conditions and 2-fold relative to noggin alone. Noggin alone increased 
the density of immature oligodendrocytes, yet when paired with PDGF, the increase was 
further enhanced. Although these cells were O4+, many cells did not exhibit a typical 
oligodendrocyte morphology. The O4 marker for differentiation is expressed at many 
stages of oligodendrocyte lineage so positive cells may not resemble the classical mature 
oligodendrocyte morphology. Furthermore, biomaterials and SCI have varying effects on 
the morphology of cells dependent on stiffness, modulus, and severity of injury (Y. 
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Aizawa, N. Leipzig, T. Zahir, & M. Shoichet, 2008; T. Lourenço & M. Grãos, 2016; S. 
R. Mciver et al., 2010; L. N. Russell & K. J. Lampe, 2017), thus cells may not exhibit 
classical morphology due to biomaterial interactions and injury. However, we note that 
O4+ cells are lineage locked to becoming myelinating oligodendrocytes (A. Nishiyama, 
M. Komitova, R. Suzuki, & X. Zhu, 2009). These findings suggest that combinatorial 
delivery of inductive factors can considerably enhance the recruitment and differentiation 
of endogenous OPCs that persist at long time points.  
Collectively, we report the ability of noggin + PDGF to promote remyelination by 
endogenous progenitor cells post-SCI. Co-delivery of noggin + PDGF encoding 
lentivirus significantly increased total myelinated axon density and percentage. Co-
delivery also promoted greater myelination by oligodendrocytes compared to all other 
conditions (22% vs 11%). This result was consistent with the increased density of O4+ 
pre-oligodendrocytes via co-delivery. Overall, we have demonstrated that lentivirus-
based expression of multiple factors, such as noggin and PDGF, from multichannel PLG 
bridges provides a strategy for identifying synergistic actions with the potential to target 
multiple barriers to regeneration.  
Bridges are increasingly being considered for both penetrating wounds as well as for 
chronic injuries in which the scar is surgically resected that creates a defect (Z. Xiao et 
al., 2016). While the bridge provides a path and support for axon regeneration, it is 
insufficient alone to promote regeneration. As we have shown, PDGF and noggin may be 
used to recruit and differentiate endogenous progenitors after spinal cord injury to 
encourage remyelination. Lentivirus represents an effective strategy to increase and 
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sustain levels of these target proteins at the injury. Lentiviral vectors are currently in 
clinical trials (M. C. Milone & U. O’doherty, 2018) and, at a minimum, represent a tool 
to identify factors or combinations of factors that enhance myelination. An alternative to 
lentivirus delivery would be the direct delivery of these proteins, which is being 
attempted by various delivery strategies (C. M. Walthers & S. K. Seidlits, 2015). This 
combination of a bridge to support and direct axon growth with a strategy to enhance 
their myelination represents a potential clinically translatable treatment for SCI.  
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Figures 
Figure 1. Noggin and PDGF expression. (A) Hoechst (blue), (B) Noggin (green), and (C) 
overlaid images of lentiviral expression of noggin. (D) Quantification of PDGF secretion 
protein from cells transfected with no virus (Control) or PDGF lentivirus using ELISA. 
Data presented as mean +/- SEM. Scale: 50 µm **** denotes p<0.0001 v. control.  
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Figure 2. Axonal Growth at 8 weeks post injury. NF-200+ (red) immunofluorescence 
from bridge implants delivering (A) FLuc, (B) Noggin, (C) PDGF, or (D) Noggin + 
PDGF. Brightness and contrast were adjusted for clarity. (E) Quantification of axon 
density in FLuc, Noggin, PDGF, and Noggin + PDGF conditions. Data presented as 
mean +/- SEM. Scale: 20 µm. N = 6 per condition. 
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Figure 3. Myelinated axons 8 weeks post injury. NF-200+ (red) /MBP+ (green) 
immunofluorescence from bridge implants delivering (A) FLuc, (B) Noggin, (C) PDGF, 
or (D) Noggin + PDGF. Brightness and contrast were adjusted for clarity. Quantification 
of (E) myelinated axon density and (F) percentage of myelinated axons in FLuc, Noggin, 
PDGF, and Noggin + PDGF conditions. Data presented as mean +/- SEM. Scale: 20 µm. 
* denotes p<0.05 v. FLuc. N = 6 per condition. 
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Figure 4. Functional recovery induced by Noggin + PDGF co-delivery. The Basso 
Mouse Scale was used to determine differences in motor recovery in the ipsilateral 
hindlimb. Data presented as mean +/- SEM. ** denotes p<0.05 v. FLuc, *** denotes 
p<0.001 v. FLuc, **** denotes p<0.0001 v. FLuc. N = 12 per condition. 
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Figure 5. Source of myelination 8 weeks post injury. Immunofluorescence from bridges 
of Schwann cell (NF-200+/MBP+/P0+: red/green/blue, respectively) and oligodendrocyte 
(NF-200+/MBP+/P0-) derived myelin fibers from bridge implants delivering lentivirus 
encoding (A) FLuc, (B) Noggin, (C) PDGF, or (D) Noggin + PDGF. White arrows show 
fibers wrapped by Schwann cell myelin. Yellow arrows show fibers wrapped by 
Oligodendrocyte myelin. Brightness and contrast were adjusted for clarity. Quantification 
of (E) oligodendrocyte myelin density and (F) percentage of oligodendrocyte-derived 
myelinated axons in FLuc, Noggin, PDGF, and Noggin + PDGF conditions. Data 
presented as mean +/- SEM. Scale: 20 µm. ** denotes p<0.01 v. FLuc, ## denotes p<0.01 
v. Noggin, ^ denotes p<0.05 v. PDGF. N = 6 per condition. 
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Figure 6. Oligodendrocyte-lineage cells in bridge implants at 8 weeks post injury. 
Images are representative of positive cell counts. (A-D) Oligodendrocyte-lineage cells at 
8 weeks post injury. (A) Hoechst, (B) NG2+, and (C) O4+ expression in bridge implants. 
(D) Merged image. Yellow arrows denote NG2+ cells. White arrows denote O4+ cells. 
Scale: 20 µm. (E-H) Neural progenitor cells at 8 weeks post injury. (E) Hoechst, (F) 
Sox2+, and (G) Olig2+ expression in bridge implants. (H) Merged image shows single 
expression and co-expression of Sox2 and Olig2. White arrows indicate positive nuclei 
for co-expression. Brightness and contrast were adjusted for clarity. Scale: 20 µm. (I) 
Schematic of infiltration of cells into bridge implants from uninjured contralateral tissue 
following injury. Cells nearest the midline migrate into the bridge to support regenerating 
axons. (J) Quantification of O4+ cells. (K) Quantification of NG2+ cells. (F) 
Quantification of neural progenitor cell phenotype densities. Data presented as mean +/- 
SEM. ** denotes p<0.01 v. FLuc, # denotes p<0.05 v. Noggin, ## denotes p<0.01 v. 
Noggin, $$ denotes p<0.01 v. Noggin + PDGF, ^^^ denotes p<0.001 v. PDGF. N = 6 per 
condition. 
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